Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-18-053649
Filing Date
2018-10-12
Accepted
2018-10-12 16:02:48
Documents
3
Group Members
DAVID E. SHAW

Document Format Files

Seq Description Document Type Size
1 SC 13G tv504734_sc13g.htm SC 13G 50913
2 EXHIBIT 1 tv504734_ex-1.htm EX-99.1 6195
3 EXHIBIT 2 tv504734_ex-2.htm EX-99.2 4372
  Complete submission text file 0001144204-18-053649.txt   63140
Mailing Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036
Business Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036 2124780000
D. E. SHAW & CO, L.P. (Filed by) CIK: 0001009268 (see all company filings)

EIN.: 133695715 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG
Business Address 3 LOTUS PARK, THE CAUSEWAY STAINES-UPON-THAMES SURREY X0 TW18 3AG 44-017-8463-6700
Mallinckrodt plc (Subject) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1229
Type: SC 13G | Act: 34 | File No.: 005-87833 | Film No.: 181120257
SIC: 2834 Pharmaceutical Preparations